Health Care Use and Costs in the Decade After Identification of Type 1 and Type 2 Diabetes
Open Access
- 1 November 2006
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (11), 2403-2408
- https://doi.org/10.2337/dc06-0735
Abstract
OBJECTIVE—To analyze trends in health care costs in the decade after identification of diabetes, contrasting type 1 and 2 diabetes. RESEARCH DESIGN AND METHODS—The Canadian National Diabetes Surveillance System criteria were applied to administrative databases to identify incident diabetes cases in 1992. Cases were categorized as type 1 or type 2 diabetes based on patterns of drug use. Per capita health care costs (in 2001 Canadian dollars) for five resource categories were estimated according to the type of diabetes, for the year before identification (1991) and 10 years after (1992–2001) identification of the cases. RESULTS—We identified 156 type 1 and 3,469 type 2 incident cases of diabetes, from a population base of ∼950,000. The mean (±SD) age of case subjects at index was 61.2 ± 16.7 years, and 54% of subjects were male. Overall annual per capita health expenditures rose considerably in the year after identification of diabetes but then stabilized at a lower level for the next 9 years, ranging from $3,800 to $4,400. From 1992 to 2001, diabetic individuals used $137.1 million in health care resources, most of which (96%) was attributable to type 2 diabetes. The average 10-year cost per individual with diabetes was $37,820 ($33,684 per type 1 and $38,006 per type 2 diabetes case; adjusted P = 0.45). CONCLUSIONS—Total health expenditures for diabetes are driven by the much larger prevalence of type 2 compared with type 1 diabetes. Policymakers need to acknowledge and allocate resources for diabetes prevention and management accordingly.Keywords
This publication has 16 references indexed in Scilit:
- “Breakthrough” drugs and growth in expenditure on prescription drugs in CanadaBMJ, 2005
- Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosisCMAJ : Canadian Medical Association Journal, 2004
- The Evolving Diabetes Burden in the United StatesAnnals of Internal Medicine, 2004
- Underuse of aspirin in type 2 diabetes mellitus: Prevalence and correlates of therapy in rural CanadaClinical Therapeutics, 2004
- Economic Costs of Diabetes in the U.S. in 2002Diabetes Care, 2003
- Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis accessAmerican Journal of Kidney Diseases, 2002
- Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S.Diabetes Care, 2002
- Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis.Diabetes Care, 2000
- A 6-year nationwide cohort study of glycaemic control in young people with Type 1 diabetesJournal of Diabetes and its Complications, 2000
- The Relation between Funding by the National Institutes of Health and the Burden of DiseaseNew England Journal of Medicine, 1999